Today we will take a look at CRISPR Therapeutics. Which are the main technical elements we can see here? a) The price is against a major Support/Resistance level, working since 2018. The price reaction on these zones tends to provide solid insight into future movements. b) Let's assume the price bounces on the current zone; what can we expect? - A...
ILLUMINA (ILMN), D1: Mirror level + Bollinger bands + 2 Hammers + Hidden divergence + Sell off
Close to its all-time low. Stochastic, RSI and money flow at the oversold point. Why would it keep falling further? I see probable a recovery to the marked lines. NASDAQ:FIXX
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy...
#SeattleGenetics is doing several impressive studies which helped stock price moved up.They stayed strong during the crash. It is doing well so far but it may stall for a while because of the coming resistances.
Hello Traders! It looks like $SGEN has made a local top and will be headed for consolidation. Not to worry, I believe continued upside potential is favored. My plan includes stacking buy orders at $90-$75 with stops at $70. Do your own DD, and good luck! Yo boy, Pic
EDIT and CRSP CRISPR-Cas9, -Cas11, -Cas12 genetic improvements for bio-pharma partnerships The next big thing to improving and repairing defects in you RNA Currently at Fibretracement 0.618 and in spot to move up or down, depending on big money theory...wahahah! but there's enough small money to pull it down, just saying for disclosure.
On the weekly note, We have a weak bullish TK cross, prices have closed above the cloud which is a good sign that the current support at $0.38 holds. Currently it is a long term hold if you are looking into buying $GSS. Short term outlook: RSI is hovering close to oversold conditions, Chaikin Money Flow is dropping and that means the buying power is weakening....
Stock tanked last year because hep b trials killed a chimp, so they shelved project to focus on Amgen and RNAi program therapies. Buy half now, buy the other half on a pullback. Fucking beautiful chart. BEAUTIFUL Only short to medium term risk is dilution, which is a very real possibility . The buying is just SO strong though, wow. BEAUTIFUL, like, it's...
See notes on chart. Widening Bollinger Bands lead to heavy up-moves before a strong pull-back. Look for significant upside before a crash.